Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Gibbons, Don L ^a   Lin, Wei ^a   Creighton, Chad J ^b   Zheng, Shuling ^a   Berel, Dror ^b   Yang, Yanan ^a   Raso, Maria Gabriela ^a   Liu, Diane D ^a   Wistuba, Ignacio I ^a   Lozano, Guillermina ^a   Kurie, Jonathan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DATA MINING; DISTANT METASTASIS; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENETIC DATABASE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROGNOSIS; TUMOR LOCALIZATION; ADENOCARCINOMA; ANIMAL; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; METASTASIS; MISSENSE MUTATION; ONCOGENE RAS; PATHOLOGY;

MUS;

ADENOCARCINOMA; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; LUNG NEOPLASMS; MICE; MUTATION, MISSENSE; NEOPLASM METASTASIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65549137486     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005401     Document Type: Article

References (19)

1. Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, et al. (2001) Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15: 3249-3262.
2. Guerra C, Mijimolle N, Dhawahir A, Dubus P, Barradas M, et al. (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4: 111-120.
3. Ji H, Houghton AM, Mariani TJ, Perera S, Kim CB, et al. (2006) K-ras activation generates an inflammatory response in lung tumors. Oncogene 25: 2105-2112.
4. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, et al. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116.
5. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, et al. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243-3248.
6. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, et al. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119: 861-872.
7. Liu G, McDonnell TJ, Montes de Oca Luna R, Kapoor M, Mims B, et al. (2000) High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Natl Acad Sci U S A 97: 4174-4179.
8. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, et al. (2004) Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119: 847-860.
9. Zheng S, El-Naggar AK, Kim ES, Kurie JM, Lozano G (2007) A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene 26: 6896-6904.
10. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98: 31-36.
11. Saldanha AJ (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
12. Creighton CJ, Nagaraja AK, Hanash SM, Matzuk MM, Gunaratne PH (2008) A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. Rna 14: 2290-2296.
13. Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, et al. (2008) Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 26: 4078-4085.
14. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98: 13790-13795.
15. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827.
16. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, et al. (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13: 1977-2000.
17. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54.
18. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98: 15149-15154.
19. Huber MA, Kraut N, Beug H (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.